New bedside test could speed up care for Life-Threatening postpartum bleeding

NCT ID NCT06255002

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 24 times

Summary

This study is testing a quick, portable device (qLabs®FIB) that measures a key blood clotting protein (fibrinogen) right at the bedside in women with severe bleeding after childbirth. The goal is to see if this rapid test gives results as accurate as the standard lab test, which takes longer. If it works, doctors could make faster treatment decisions, potentially saving lives. The study will involve 70 adult women with severe postpartum hemorrhage.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Cochin Maternité Port Royal

    RECRUITING

    Paris, 75014, France

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Hôpital Necker-Enfants Malades

    RECRUITING

    Paris, 75015, France

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.